David Adelstein, M.D

Internal Medicine, Hematology & Oncology

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

CLEVELAND, OH

QC-verified· April 2026 PI on 1 trialNPI: 1922061365

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Adenocarcinoma of the oesophagus and oesophagogastric junction

Clinical trials (1)

NCT01395537

Verify independently

ClinicalTrials.gov PI search for David Adelstein
NPPES NPI registry entry

Other specialists for Adenocarcinoma of the oesophagus and oesophagogastric junction

Peers ranked by clinical-trial PI role, publications, and verification quality.

Global Clinical Leader
Daiichi Sankyo
Manuel Häckl, MD
Basilea Pharmaceutica International Ltd, Allschwil
Howard Safran, MD, M.D
BrUOG
RI
Syma Iqbal, MD, M.D
University of Southern California
CA
Executive Director
Astellas Pharma Global Development, Inc.
Lakshmi Rajdev, MD
ECOG-ACRIN Cancer Research Group
NY
Vincent Chung, MD, MD
City of Hope Medical Center
CA
Michael Cecchini, DPT
Yale University Cancer Center LAO
MD

See all specialists for Adenocarcinoma of the oesophagus and oesophagogastric junction →

← Back to specialists directory